The estimated Net Worth of David Mc Intyre is at least 8.55 千$ dollars as of 16 July 2020. David Intyre owns over 693 units of AVITA Medical Inc stock worth over 8,546$ and over the last 4 years David sold RCEL stock worth over 0$.
Sign up
David Intyre RCEL stock SEC Form 4 insiders trading
David has made over 1 trades of the AVITA Medical Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently David bought 693 units of RCEL stock worth 16,078$ on 16 July 2020.
The largest trade David's ever made was buying 693 units of AVITA Medical Inc stock on 16 July 2020 worth over 16,078$. On average, David trades about 693 units every 0 days since 2020. As of 16 July 2020 David still owns at least 893 units of AVITA Medical Inc stock.
You can see the complete history of David Intyre stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's David Intyre's mailing address?
David's mailing address filed with the SEC is C/O AVITA THERAPEUTICS, INC., 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355.
Insiders trading at AVITA Medical Inc
Over the last 5 years, insiders at AVITA Medical Inc have traded over 2,850,472$ worth of AVITA Medical Inc stock and bought 19,459 units worth 293,310$ . The most active insiders traders include Michael S Perry、James Corbett、David D O'toole. On average, AVITA Medical Inc executives and independent directors trade stock every 82 days with the average trade being worth of 135,636$. The most recent stock trade was executed by David D O'toole on 30 May 2024, trading 1,000 units of RCEL stock currently worth 8,900$.
What does AVITA Medical Inc do?
avita medical (http://www.avitamedical.com/) is a publicly listed regenerative medicine company trading on the australian stock exchange (asx:avh) and otc markets (otcqx:avmxy). the company’s lead product, recell® is used in a wide variety of burns, chronic wounds, plastic, reconstructive and cosmetic procedures. recell is patented, ce-marked for europe, tga- registered in australia, and sfda-cleared in china. recell is not available for sale in the united states; in the us recell is an investigational device limited by federal law to investigational use.
What does AVITA Medical Inc's logo look like?
Complete history of David Intyre stock trades at AVITA Medical Inc
AVITA Medical Inc executives and stock owners
AVITA Medical Inc executives and other stock owners filed with the SEC include:
-
Dr. Michael S. Perry D.V.M., DVM, FACVPT, Ph.D.,
CEO, Pres & Exec. Director -
Erin Liberto,
Chief Commercial Officer -
Andrew Quick,
Chief Technology Officer -
Donna Shiroma,
Gen. Counsel & Sec. -
Michael Bria Holder MBA,
Chief Financial Officer -
Kathy M. McGee,
Chief Operating Officer -
Debbie Garner,
VP of Global Marketing -
David Fencil,
VP of Global Operations -
Sean Ekins,
Interim CFO -
Donna Shiroma,
General Counsel -
David Mc Intyre,
Chief Financial Officer -
Erin Liberto,
Chief Commercial Officer -
David D O'toole,
CFO -
Suzanne Crowe,
-
James Corbett,
CEO -
Kathy M. Mc Gee,
Chief Operating Officer -
Michael Holder,
Chief Financial Officer -
Lou Panaccio,
-
Louis Drapeau,
Director -
Jeremy Curnock Cook,
-
Michael S Perry,
Director -
Cary Guy Vance,
-
Robert Mc Namara,
-
Jan Stern Reed,